首页> 外国专利> method for medicamental correction of oxidative stress in clinically aspirine-resistent patient at unstable angina pectoris without ST segment increasing

method for medicamental correction of oxidative stress in clinically aspirine-resistent patient at unstable angina pectoris without ST segment increasing

机译:临床上对阿司匹林耐药的不稳定型心绞痛患者的氧化应激的药物校正方法

摘要

A method for medicamental correction of oxidative stress in clinically aspirine-resistent patients at unstable angina pectoris without ST segment increasing, that in complex standard therapy (by anticoagulants, antianginal and antisclerotic means) comprises the antithrombocyte therapy (acetylsalicylic acid). The antithrombocyte therapy is prescribed as double one, acetylsalicylic acid and Clopidogrel. To the patients in which destabilization of disease occurs on the background of preliminary intake of acetylsalicylic acid, immediately after hospitalization additionally to double antithrombocyte therapy a metabolic preparation is prescribed having antioxidant characteristics, namely Corvitin®.
机译:在不增加ST段的情况下,在不稳定型心绞痛的临床上对阿司匹林耐药的患者中氧化应激的药物校正方法,在复杂的标准疗法中(通过抗凝剂,抗心绞痛和抗硬化手段)包括抗血小板疗法(乙酰水杨酸)。抗血小板疗法被指定为双重疗法,乙酰水杨酸和氯吡格雷。对于在最初摄入乙酰水杨酸的情况下发生疾病不稳定的患者,在住院后立即除了双重抗血小板治疗外,还应开具具有抗氧化特性的代谢制剂,即Corvitin®。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号